Deletions of these genes in individuals with type 1 SMA likely reflect large-scale deletions involving the SMN1 gene and some copies of the SMN2 gene, leading to a severe phenotype due to a lack of the SMN protein product [86]. This evidence concerns the gene SMN2 and spinal muscular atrophy, type 1.